Liposomes were preincubated for 30 min with the LDs: sigma-2 receptor ligand siramesine (10 μM) and the receptor tyrosine kinase (RTK) inhibitor sunitinib (10 μM), currently used for the treatment of renal cell cancer. Here, NTRK1 is linked to renal cell adenocarcinoma.